ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
| Revenue (TTM) | $5.54B |
| Gross Profit (TTM) | $3.44B |
| EBITDA | $2.12B |
| Operating Margin | 35.30% |
| Return on Equity | 25.30% |
| Return on Assets | 14.70% |
| Revenue/Share (TTM) | $37.94 |
| Book Value | $44.76 |
| Price-to-Book | 4.65 |
| Price-to-Sales (TTM) | 5.45 |
| EV/Revenue | 5.3 |
| EV/EBITDA | 13.47 |
| Quarterly Earnings Growth (YoY) | 10.50% |
| Quarterly Revenue Growth (YoY) | 10.80% |
| Shares Outstanding | $145.06M |
| Float | $144.17M |
| % Insiders | 0.50% |
| % Institutions | 69.94% |
Volatility is currently expanding